Grant Avenue Capital is a healthcare-focused private equity firm investing alongside forward-thinking management teams seeking an experienced and innovative investor with operational insight and flexible growth capital. 

The team is committed to delivering outstanding, risk-adjusted results for investors by actively building world-class companies that enhance patient health, improve the overall healthcare system and positively impact communities. 

Based on underlying sector trends, Grant Avenue Capital pursues opportunities in companies with approximately $5 million to 25 million of EBITDA across healthcare, including Services, Devices, Pharma & Pharma Services and HCIT, that relate to our core investment themes: 

Cost Containment: Products or services that reduce overall healthcare cost and generate strong clinical outcomes 
Custom Solutions: Service companies with outsourcing or technology solutions that drive efficiency, reduce expenses and improve results 
Consumerism: Retail or other consumer-oriented health and wellness services or products that provide individuals more personalized care options 
Compliance: Tech-enabled businesses that attack fraud, waste and abuse or ensure payment compliance 

Health Care

Health Data

Pharmaceutical

Grant Avenue Capital

Grant Avenue Capital's headquarters in New York, United States

Buddy Gumina

Teresa Johnson

Preston Brice

G Stephen Decherney

Laura Kargbo

Stewart Jamieson

Brian Berkin

Grant Avenue Capital

Org chart

Teams

Offices

Similar companies